读者回应：抗凝患者中的MT：直接口服抗凝剂与维生素K拮抗剂 - Suppr | 超能文献

Reader response: MT in anticoagulated patients: Direct oral anticoagulants versus vitamin K antagonists.

作者信息

Frontera Jennifer A

机构信息

(New York).

出版信息

Neurology. 2020 Nov 17;95(20):939-940. doi: 10.1212/WNL.0000000000010975.

DOI:10.1212/WNL.0000000000010975

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Reader response: MT in anticoagulated patients: Direct oral anticoagulants versus vitamin K antagonists.读者回应：抗凝患者中的MT：直接口服抗凝剂与维生素K拮抗剂

Neurology. 2020 Nov 17;95(20):939-940. doi: 10.1212/WNL.0000000000010975.

2

POST-NOAC: Portuguese observational study of intracranial hemorrhage on non-vitamin K antagonist oral anticoagulants.非维生素 K 拮抗剂口服抗凝剂相关颅内出血的葡萄牙观察性研究。

Int J Stroke. 2017 Aug;12(6):623-627. doi: 10.1177/1747493016681021. Epub 2016 Dec 1.

3

Commentary: Should patients awaiting cardiac surgery who need anticoagulation be on direct oral anticoagulants or vitamin K antagonists?

J Thorac Cardiovasc Surg. 2021 May;161(5):1876-1877. doi: 10.1016/j.jtcvs.2019.12.102. Epub 2020 Jan 21.

4

What Is the Efficacy and Safety of Direct Oral Anticoagulants Compared With that of Vitamin K Antagonists in Patients With Cerebral Vein Thrombosis?在脑静脉血栓形成患者中，直接口服抗凝剂与维生素K拮抗剂相比，其疗效和安全性如何？

Ann Emerg Med. 2022 Oct;80(4):329-331. doi: 10.1016/j.annemergmed.2022.05.007. Epub 2022 Jun 16.

5

[Oral anticoagulation in atrial fibrillation: differential therapy with non vitamin K antagonist oral anticoagulants (NOAC) and vitamin K antagonists (VKA)].心房颤动的口服抗凝治疗：非维生素K拮抗剂口服抗凝药（NOAC）与维生素K拮抗剂（VKA）的差异化治疗

MMW Fortschr Med. 2019 Oct;161(Suppl 6):15-23. doi: 10.1007/s15006-019-0920-y. Epub 2019 Oct 5.

6

[Risk of vitamin K antagonists in cases of cerebral microbleeds].[脑微出血病例中维生素K拮抗剂的风险]

Ned Tijdschr Geneeskd. 2018;162:D1790.

7

MT in anticoagulated patients: Direct oral anticoagulants versus vitamin K antagonists.在抗凝患者中的 MT：直接口服抗凝剂与维生素 K 拮抗剂。

Neurology. 2020 Feb 25;94(8):e842-e850. doi: 10.1212/WNL.0000000000008873. Epub 2020 Jan 20.

8

Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?在直接口服抗凝剂时代的维生素K拮抗剂：它们还有使用空间吗？

Intern Emerg Med. 2017 Dec;12(8):1087-1089. doi: 10.1007/s11739-017-1725-6. Epub 2017 Aug 4.

9

Direct oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: a systematic review of the literature and meta-analysis.直接口服抗凝剂与维生素K拮抗剂治疗左心室血栓形成的系统文献综述和荟萃分析

Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e21-e25. doi: 10.1093/ehjcvp/pvaa134.

10

Safety of Endovascular Thrombectomy for Acute Ischaemic Stroke in Anticoagulated Patients Ineligible for Intravenous Thrombolysis.抗凝治疗且不符合静脉溶栓条件的急性缺血性卒中患者血管内血栓切除术的安全性

Cerebrovasc Dis. 2018;46(5-6):193-199. doi: 10.1159/000493801. Epub 2018 Nov 1.

引用本文的文献

1

Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19.多国住院 COVID-19 患者的神经表型特征描述。

Sci Rep. 2021 Oct 12;11(1):20238. doi: 10.1038/s41598-021-99481-9.

2

SARS-CoV-2 Infection: Symptoms of the Nervous System and Implications for Therapy in Neurological Disorders.严重急性呼吸综合征冠状病毒2感染：神经系统症状及其对神经系统疾病治疗的影响

Neurol Ther. 2021 Jun;10(1):31-42. doi: 10.1007/s40120-020-00225-0. Epub 2020 Nov 23.